Does Palliative Chemotherapy Palliate? Measuring symptom benefit in recurrent ovarian cancer using patient reported outcomes: The Symptom Benefit Study [ 2014 - 2015 ]

Research Grant

Researchers: Prof Michael Friedlander (Principal investigator) ,  Dr Chee Khoon Lee ,  Dr Julie Martyn ,  Dr Katrin Sjoquist ,  Dr Rachel O'Connell
View all 8 related researchers

Brief description Clinical trials for women with recurrent ovarian cancer traditionally use a reduction in tumour size and time to progression to measure the benefit of chemotherapy, but do not document whether women have symptom improvement as well. The aim of the Symptom Benefit Study is to validate an instrument that will allow patients to report their symptoms and degree of improvement and for the first time allow clinical trials to include a measure of symptom improvement when new drugs are being tested.

Funding Amount $AUD 405,024.94

Funding Scheme Project Grants

Notes Standard Project Grant